Transdermal Pain Relief and Skin Irritation Treatment Compositions

This inventive concept leverages the core technology of the original patent to develop novel transdermal compositions for rapid pain relief and skin irritation treatment in various applications beyond oral pain relief.

The original patent addressed oral pain relief through dissolvable compositions. However, the same core technology can be adapted to address unmet needs in other areas, such as skin irritation, joint inflammation, sunburn, insect bites, and minor cuts and scrapes. Current treatments for these conditions often have limited efficacy, are slow-acting, or have undesirable side effects. The new inventive concept solves this problem by providing targeted, rapid, and effective pain relief and skin irritation treatment through transdermal delivery.

The new inventive concept involves the development of dissolvable carriers containing at least one active ingredient selected from guaiacol, eugenol, glycerin, menthol oil, peppermint oil, oregano oil, and cardamom oil. These carriers are designed to adhere to surfaces exhibiting skin irritation, joint inflammation, or other conditions, and dissolve over time to release the active ingredients. The compositions can be administered through various methods, including topical application, injection, or implantation, depending on the specific application. The active ingredients work synergistically to provide rapid pain relief, reduce inflammation, and promote healing.

The new inventive concept introduces a novel transdermal delivery mechanism for the original patent's active ingredients, expanding their application beyond oral pain relief. The inventive step lies in the adaptation of the core technology to address distinct problems in various fields, including dermatology, rheumatology, and wound care.

Alternative embodiments may include varying the composition's active ingredients, carrier materials, or delivery methods to suit specific applications. For example, the composition could be formulated as a spray, gel, or cream for topical application, or as a biodegradable implant for sustained release. Additionally, the inventive concept could be combined with other therapies, such as physical therapy or light therapy, to enhance its effectiveness.

The new inventive concept has significant commercial potential in various industries, including pharmaceuticals, cosmetics, and medical devices. Target markets include dermatology clinics, sports medicine centers, and wound care facilities. The compositions could be marketed as over-the-counter or prescription products, depending on the specific application and regulatory requirements.